234080.KS
JW Lifescience Corporation
KSC · Healthcare · Drug Manufacturers - Specialty & Generic · KR
KRW 11,200.00
−1.67%Margins
Gross margin
27.4%
EBITDA margin
20.4%
EBIT margin
13.1%
Net margin
10.3%
FCF margin
14.0%
11.5%
Return on equity
8.5%
Return on assets
12.9%
Return on invested capital
0.82x
Asset turnover
KRW 48.0B
Cash from operations
KRW 583
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026